Celerion
Agent38Agent Readiness: 38/100. Below median. Measured by StartupHub.ai. Median 41.Trust79Data Trust: 79/100. Top 25%. Measured by StartupHub.ai. Median 61.A global leader in clinical pharmacology and bioanalytical sciences.
About
Celerion is a global leader in clinical pharmacology and bioanalytical sciences, providing services to pharmaceutical and biotechnology companies to help bring new therapies to patients. They focus on early-stage drug development, offering expertise in bioanalytical testing, clinical pharmacology studies, and data management.
Listed competitors
Clinical research organization providing software and data analytics for drug development.
A global contract research organization providing essential drug discovery and development services.
AI-powered voice analysis for non-invasive drug and alcohol intoxication detection.
Global life sciences company providing diagnostic and biopharma laboratory services.
Integrated drug development solutions for pharmaceutical and biotechnology companies, from preclinical to clinical trials.
A leading Contract Research Organisation (CRO) specializing in early-phase clinical trials for pharmaceutical and biotechnology companies.
Also in this space
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Biotech
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Life Sciences
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Shares Biotechnology, Healthcare
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Shares Biotechnology, Drug Discovery
Key facts
- Website
- celerion.com
- Headquarters
- Lincoln, Nebraska, USA
- Founded
- 1975
- Employees
- 1,162
- Total funding
- $45M (Majority Investment)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 22 Apr 2026 | Majority Investment | Undisclosed | THL Partners |
| 1 Oct 2022 | Buyout/LBO | $45M | Bain Capital Ventures (BCV) |
Tech stack
Detected on celerion.com, last scanned 28 Oct 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Tag Manager
- SEO
- All in One SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
- Email marketing
- Salesforce Pardot
- Video / media
- YouTube
Celerion scores 45. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Celerion trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Celerion is 79 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Celerion raised?
Celerion has raised a total of $45M in funding. The most recent round on record is Majority Investment.
How many employees does Celerion have?
Celerion has approximately 1,162 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Celerion
